Asia Consortium logo

ISPOR Asia Consortium Advisory Committee Membership

The Asia Consortium Advisory Committee is an advisory group comprising key individuals who are highly-regarded experts in the field of health economics and outcomes research (HEOR), and have demonstrated a continuing interest in advancing the science of HEOR and promoting evidence-informed health care decision-making by the use of this science in Asia.

The role of the Advisory Committee is to provide strategic and scientific support and guidance to the Asia Consortium on new initiatives, health science or health policy issues, and other activities of the Asia Consortium.

In general, the Advisory Committee includes the Chair, the Chair-Elect, and approximately 20 members. Additional experts with special knowledge may be added to the committee as needed.

Asia Consortium Advisory Committee Members (2017-2019)

2017-2019 Chair
Bruce Crawford, MPH, MA

Bruce Crawford, MPH, MA
Vice President, Real World Evidence & Insights, inVentiv Health Japan G.K., Tokyo, Japan

2017-2019 Chair-Elect
Chee-Jen Chang, PhD

Chee-Jen Chang, PhD
Director, Clinical Informatics and Medical Statistics Research Center and Professor, Graduate Institute of Clinical Medical Sciences, Chang Gung University, TaoYuan, Taiwan


Jeonghoon Ahn, PhD, MA

Jeonghoon Ahn, PhD, MA
Associate Professor, Department of Health Convergence, EWHA Womans University, Seoul, South Korea

Nathorn Chaiyakunapruk, Pharm.D., PhD

Nathorn Chaiyakunapruk, Pharm.D., PhD
Professor of Health Economics, School of Pharmacy, Monash University Malaysia, Selangor, Malaysia

Alex Z. Fu, PhD

Alex Z. Fu, PhD
Associate Professor, Department of Oncology, Georgetown University Medical Center, Washington, DC, USA

Jeff J. Guo, BPharm, PhD

Jeff J. Guo, BPharm, PhD
Professor, Pharmacy Practice & Administrative Sciences, University of Cincinnati College of Pharmacy, Cincinnati, Ohio, USA

Eui-Kyung Lee, PhD, RPh

Eui-Kyung Lee, PhD, RPh
Professor, SungKyunKwan University (SKKU), Seoul, South Korea

Vivian WY Lee, BSc, PharmD, BCPS

Vivian WY Lee, BSc, PharmD, BCPS (Added Qualification in Cardiology)
Associate Professor, School of Pharmacy, and Assistant Dean (Student Development), Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong

Hong Li, PhD, MPH

Hong Li, PhD, MPH
Lead, Trans-Pacific Outcomes Research (TOR) LLC, USA

Surachat Ngorsuraches, PhD

Surachat Ngorsuraches, PhD
Associate Professor, College of Pharmacy and Allied Health Professions, South Dakota State University, Brookings, South Dakota, USA

Jennifer C. Sung, PharmD, MS, MBA

Jennifer C. Sung, PharmD, MS, MBA
Head, Cardiovascular HE&OR, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA

Jianwei Xuan MD, PhD

Jianwei Xuan MD, PhD
Professor and Director, Health Economic Research Institute, Sun Yat-sen University, Guangzhou, China

SeungJin Bae, Sc.D., R.Ph

SeungJin Bae, Sc.D., R.Ph
Associate Professor, Ewha Womens University, College of Pharmacy, Seoul, South Korea

Ruoyan Gai, MSc, PhD

Ruoyan Gai, MSc, PhD
Chief, Division of Policy Evaluation, Department of Health Policy, and Chief, Division of Health Technology Assessment, Department of Clinical Epidemiology, National Center for Child Health and Development, Tokyo, Japan

Allen Lai, PhD, MD, MSc

Allen Lai, PhD, MD, MSc
Regional Managing Director, ACT Genomics, Singapore

Kenneth KC Lee, PhD

Kenneth KC Lee, BSc(Pharm), MPhil, PhD, Reg Pharm (HK)
Professor of Pharmacy, School of Pharmacy, Monash University, Selangor, Malaysia

Shu Chuen Li, MApplSc, MBA, PhD

Shu Chuen Li, MApplSc, MBA, PhD
Chair Professor of Pharmacy & Head of Pharmacy and Experimental Pharmacology, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia

Xin Sun, PhD

Xin Sun, PhD
Professor and Director, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China

Jing Wu, PHD

Jing Wu, PHD
Professor, Pharmaceutical Economics and Policy, Tianjin University, Tianjin, China

Ming-Chin Yang, PhD

Ming-Chin Yang, PhD
Professor, Institute of Health Policy and Management, National Taiwan University, Taipei, Taiwan

Mingliang Zhang, PhD

Mingliang Zhang, PhD
Senior Director, Design and Analytics, Real World Evidence Janssen Scientific Affairs, Titusville, NJ, USA